NCT00262275View on ClinicalTrials.gov

Optimum Platelet Inhibition After Coronary Bypass Surgery

NACompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2002

Primary Completion Date

July 31, 2004

Conditions
Ischemic Heart Disease
Interventions
DRUG

Aspirin, Clopidogrel

Trial Locations (1)

CB3 8RE

Papworth Hospital, Cambridge

All Listed Sponsors
lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT00262275 - Optimum Platelet Inhibition After Coronary Bypass Surgery | Biotech Hunter | Biotech Hunter